Soy supplement for babies at high risk of asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This Phase 2 study tests whether daily soy isoflavones can lower the chance of asthma or wheezing problems in babies who are at high risk. You would join because your baby has risk factors (family history and certain genetics) and receives the study soy product.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A parent or guardian is at least 18 years old and can give written consent.
- Your baby was born at term (37+ weeks) and is under 12 months old when the study starts.
- Your baby is high risk for asthma based on family history and/or an allergy/skin condition like eczema.
- Your baby has a specific PAI-1 gene result (4G4G or 4G5G).
- You live in a study area (a specific neighborhood zone) or in the wider metro area with publicly funded health insurance.
- Your baby can take the study medicine by liquid (breast milk or formula) or puree, and cannot already be on soy formula.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a soy-based supplement to infants with a viral chest infection can reduce wheezing and other symptoms. It aims to see if this natural compound helps the immune system fight the virus.
This study tests if the medicine Dupilumab can help control asthma and wheezing in children ages 2 to just under 6. It is for children whose symptoms are not well-managed with their current inhaler.
This study tests if giving oral steroids (medicine to reduce airway swelling) only when needed based on a child's own biology can help preschool children with wheezing. It aims to find the best treatment for each child, avoiding unnecessary medicine.
This study tests whether a high-dose vitamin D supplement can help preschool children have fewer acute asthma-like symptoms (coughing, wheezing, or trouble breathing) that require hospital care. It may help by supporting the immune and airway system, but you can only join if the child meets several safety and treatment criteria.
This study follows children with wheezing (in younger kids) or doctor-diagnosed asthma (in older kids). It aims to better understand asthma and related breathing problems and how they develop over time.
This trial studies whether an early steroid treatment can lower the chance that children will go on to develop asthma after their first severe “wheezing” episode caused by a rhinovirus (a common cold virus). If you qualify, the goal is to prevent future asthma rather than just treat the current episode.
Hear when a new Wheezing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.